Adds new requirements for obtaining an initial license to operate and maintain a hospice program.
SB 1575 revises Oregon’s hospice licensing laws to impose substantially tighter controls on new hospice program licenses and renewals. The bill amends ORS 443.860 to require the Oregon Health Authority (OHA) to establish application and renewal fees by rule, conduct criminal records checks on key owners and administrators, and review applicants’ negative performance history, including prior license sanctions, fraud or abuse findings, and exclusions from Medicare or Medicaid. It also authorizes OHA to deny, suspend, or revoke licenses for knowingly false information and bars ownership interests by persons excluded from federal health care programs or found liable for health care fraud or abuse.
The bill adds new authority for OHA to require out-of-state performance history and past survey results, and it conditions licensure on submission of consumer assessment survey results to the Centers for Medicare and Medicaid Services when applicable. It also directs OHA to complete rulemaking within 24 months and creates a temporary moratorium on new initial hospice licenses until that rulemaking is finished, with limited exceptions for existing hospice providers expanding service areas or changing ownership, certain licensed health care providers and facilities, and applicants serving underserved areas or populations. The moratorium section sunsets on January 2, 2029, and the act takes effect immediately as an emergency measure.
The bill’s impact on state law is to shift hospice oversight toward a more rigorous, risk-based licensing framework and to give OHA broader screening and enforcement tools. It changes the licensing process for hospice programs, expands the information applicants must disclose, and allows the agency to use rulemaking to set fees, qualifications, and denial criteria. It also temporarily restricts market entry for new hospice providers, which is intended to slow rapid growth while standards are strengthened.
Overall sentiment around the bill appears broadly supportive. The vote history shows strong approval in both chambers, including a 19-8 Senate floor vote and a 49-1 House floor vote, suggesting bipartisan concern about hospice quality and fraud prevention. The bill’s findings emphasize protecting terminally ill patients and their families, and the emergency clause indicates lawmakers viewed the issue as urgent.
The main point of contention is the balance between consumer protection and access to care. Supporters appear to favor the moratorium and stricter vetting to prevent unqualified or fraudulent providers, while the exceptions for underserved areas and existing providers suggest concern that a blanket freeze could limit access in rural, frontier, medically underserved, or otherwise vulnerable communities. The limited committee opposition reflected in the votes likely centered on whether the temporary licensing pause could delay needed hospice expansion or create barriers for new entrants.
SB 1575 amends Oregon’s hospice licensing statute, ORS 443.860, and adds new provisions to ORS 443.850 to 443.869. It requires OHA to adopt rules for licensing fees, application procedures, criminal background checks, performance-history review, and enforcement actions, while also imposing a temporary moratorium on new initial hospice licenses until those rules are completed. The bill affects hospice providers, owners, administrators, medical directors, and applicants seeking to enter or expand in the hospice market, with exceptions for certain existing providers and underserved areas.
The bill appears to have received generally favorable and bipartisan support, with strong majorities in both chambers and only limited recorded opposition. The legislative findings and emergency clause frame the measure as a patient-protection and anti-fraud response to concerns about hospice quality and rapid provider proliferation. The votes suggest lawmakers largely agreed that stronger oversight was needed, even if some members were concerned about the licensing freeze.
The primary tension in SB 1575 is between tightening oversight of hospice providers and preserving access to hospice services. Supporters emphasized preventing unqualified or fraudulent providers and giving OHA time to strengthen standards, while the exceptions in the moratorium reflect concern that new restrictions could reduce access in rural, frontier, medically underserved, and other underserved communities. Any opposition likely focused on the temporary halt to new licenses and the possibility that stricter screening could slow expansion or create barriers for legitimate providers.